A review of respiratory syncytial virus infection in infants and children.
By the age of 2, nearly every child becomes infected with the respiratory syncytial virus (RSV), the most common cause of lower respiratory tract infections (RTIs) in infants and children. Yearly epidemics occur from October to May. Most infections are mild, producing nothing more than a cold, and can be managed at home. Some cases, however, are more severe, leading to bronchiolitis, pneumonitis, pneumonia, and even death.
Choy
G
G
Department of Pharmacy Practice, School of Pharmacy, University of the Pacific, Stockton, Calif. 95211, USA.
D000998:Antiviral Agents / Q000627:therapeutic use; D002675:Child, Preschool; D006760:Hospitalization; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy* / Q000635:transmission; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous; D012254:Ribavirin